New patent for Azurity drug NYMALIZE

   August 27, 2022    Comments Off on New patent for Azurity drug NYMALIZE    Posted in: Patent Added

Annual Drug Patent Expirations for NYMALIZE Nymalize is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are five patents protecting…

The post New patent for Azurity drug NYMALIZE appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog